265 related articles for article (PubMed ID: 18840432)
1. Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver.
Oishi K; Uchida D; Ishida N
FEBS Lett; 2008 Oct; 582(25-26):3639-42. PubMed ID: 18840432
[TBL] [Abstract][Full Text] [Related]
2. PPARalpha is a potential therapeutic target of drugs to treat circadian rhythm sleep disorders.
Shirai H; Oishi K; Kudo T; Shibata S; Ishida N
Biochem Biophys Res Commun; 2007 Jun; 357(3):679-82. PubMed ID: 17449013
[TBL] [Abstract][Full Text] [Related]
3. PPARalpha is a key regulator of hepatic FGF21.
Lundåsen T; Hunt MC; Nilsson LM; Sanyal S; Angelin B; Alexson SE; Rudling M
Biochem Biophys Res Commun; 2007 Aug; 360(2):437-40. PubMed ID: 17601491
[TBL] [Abstract][Full Text] [Related]
4. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.
Inagaki T; Dutchak P; Zhao G; Ding X; Gautron L; Parameswara V; Li Y; Goetz R; Mohammadi M; Esser V; Elmquist JK; Gerard RD; Burgess SC; Hammer RE; Mangelsdorf DJ; Kliewer SA
Cell Metab; 2007 Jun; 5(6):415-25. PubMed ID: 17550777
[TBL] [Abstract][Full Text] [Related]
5. Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner.
Oishi K; Koyanagi S; Matsunaga N; Kadota K; Ikeda E; Hayashida S; Kuramoto Y; Shimeno H; Soeda S; Ohdo S
Mol Pharmacol; 2010 Jul; 78(1):135-41. PubMed ID: 20400680
[TBL] [Abstract][Full Text] [Related]
6. PPARα deficiency augments a ketogenic diet-induced circadian PAI-1 expression possibly through PPARγ activation in the liver.
Oishi K; Uchida D; Ohkura N; Horie S
Biochem Biophys Res Commun; 2010 Oct; 401(2):313-8. PubMed ID: 20854792
[TBL] [Abstract][Full Text] [Related]
7. PPARalpha is involved in photoentrainment of the circadian clock.
Oishi K; Shirai H; Ishida N
Neuroreport; 2008 Mar; 19(4):487-9. PubMed ID: 18287953
[TBL] [Abstract][Full Text] [Related]
8. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol-lowering effect of bezafibrate is independent of peroxisome proliferator-activated receptor activation in mice.
Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Hara A; Hu R; Li G; Li Y; Nakamura K; Gonzalez FJ; Aoyama T
Biochem Pharmacol; 2008 Jul; 76(1):108-19. PubMed ID: 18486101
[TBL] [Abstract][Full Text] [Related]
10. A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver.
Knight BL; Hebbachi A; Hauton D; Brown AM; Wiggins D; Patel DD; Gibbons GF
Biochem J; 2005 Jul; 389(Pt 2):413-21. PubMed ID: 15777286
[TBL] [Abstract][Full Text] [Related]
11. Effect of peroxisome proliferator-activated receptor alpha on human angiotensinogen promoter.
Shimamoto Y; Hirota K; Fukamizu A
Int J Mol Med; 2004 May; 13(5):729-33. PubMed ID: 15067378
[TBL] [Abstract][Full Text] [Related]
12. CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor alpha (PPARalpha) in mice.
Oishi K; Shirai H; Ishida N
Biochem J; 2005 Mar; 386(Pt 3):575-81. PubMed ID: 15500444
[TBL] [Abstract][Full Text] [Related]
13. Diminished diet-induced hyperglycemia and dyslipidemia and enhanced expression of PPARalpha and FGF21 in mice with hepatic ablation of brain-derived neurotropic factor.
Teillon S; Calderon GA; Rios M
J Endocrinol; 2010 Apr; 205(1):37-47. PubMed ID: 20097691
[TBL] [Abstract][Full Text] [Related]
14. FGF21 is dispensable for hypothermia induced by fasting in mice.
Oishi K; Sakamoto K; Konishi M; Murata Y; Itoh N; Sei H
Neuro Endocrinol Lett; 2010; 31(2):198-202. PubMed ID: 20424589
[TBL] [Abstract][Full Text] [Related]
15. The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.
Stienstra R; Mandard S; Tan NS; Wahli W; Trautwein C; Richardson TA; Lichtenauer-Kaligis E; Kersten S; Müller M
J Hepatol; 2007 May; 46(5):869-77. PubMed ID: 17321000
[TBL] [Abstract][Full Text] [Related]
16. Time-imposed daily restricted feeding induces rhythmic expression of Fgf21 in white adipose tissue of mice.
Oishi K; Konishi M; Murata Y; Itoh N
Biochem Biophys Res Commun; 2011 Aug; 412(2):396-400. PubMed ID: 21835167
[TBL] [Abstract][Full Text] [Related]
17. PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes.
Nakamachi T; Nomiyama T; Gizard F; Heywood EB; Jones KL; Zhao Y; Fuentes L; Takebayashi K; Aso Y; Staels B; Inukai T; Bruemmer D
Diabetes; 2007 Jun; 56(6):1662-70. PubMed ID: 17360982
[TBL] [Abstract][Full Text] [Related]
18. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.
Gälman C; Lundåsen T; Kharitonenkov A; Bina HA; Eriksson M; Hafström I; Dahlin M; Amark P; Angelin B; Rudling M
Cell Metab; 2008 Aug; 8(2):169-74. PubMed ID: 18680716
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor α (PPARα) activation advances locomotor activity and feeding daily rhythms in mice.
Gutman R; Barnea M; Haviv L; Chapnik N; Froy O
Int J Obes (Lond); 2012 Aug; 36(8):1131-4. PubMed ID: 22064158
[TBL] [Abstract][Full Text] [Related]
20. Conjugated linoleic acid induces hepatic expression of fibroblast growth factor 21 through PPAR-α.
Yu J; Yu B; Jiang H; Chen D
Br J Nutr; 2012 Feb; 107(4):461-5. PubMed ID: 21767451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
